Stronger anticoagulation therapy may be needed for patients with metastatic cancer after bone lesion surgery
the ONA take:
A high risk for venous thromboembolism (VTE) following surgery for long-bone reconstruction was found in patients with metastatic cancer.
These findings from a study by Sidney Kimmel Medical College at Thomas Jefferson University researchers were published in Journal of Bone and Joint Surgery.
The researchers retrospectively reviewed 336 cases in which patients underwent intramedullary nailing for metastatic bone lesions.
Results demonstrated that VTEs developed in 24 patients (7.1%) in the 90 days after surgery, but they also found a low incidence of postoperative wound complications (3.1%).
In addition, 66% of the patients who had developed blood clots also had a primary cancer of the lung. Additional findings were that patients who did not receive radiotherapy after surgery had a slightly lower risk of developing a blood clot.
The researchers conclude that these findings suggest anticoagulation agent, as well as duration of therapy, should be individualized to each patient and their primary cancer. Anticoagulation therapy should also be managed with a team approach that includes the oncologic, medical, radiation, and surgical teams.
A high risk for venous thromboembolism following surgery for long-bone reconstruction was found in patients with metastatic cancer.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Targeting AR Mutations Promising in Metastatic Prostate Cancer
- GUCS 2017: Early Immunotherapy Discontinuation in mRCC
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Myalgia-arthralgia Syndrome Associated With Taxanes in Patients with Breast Cancer
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|